Rabbit Anti-Human AHSA1 pAb
-
Product Number
PA16242
-
Alias
AHSA1, AHA1, C14orf3, hAha1, p38
-
Specifications
- 50ul
- 100ul
Product Description
| Alias | AHSA1, AHA1, C14orf3, hAha1, p38 |
| Catalog Number | PA16242 |
| Molecular Name | AHSA1 |
| Host | Rabbit |
| Size | 50ul, 100ul |
| Clonity | Polyclonal |
| Purification | Affinity Purification |
| Formulation | Supply in PBS with 0.02% sodium azide, 50% glycerol, pH 7.4. |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to a.a. 1-338 of human AHSA1 (NP_036243.1). |
| Application | WB |
| Storage Condition | Store the product under sterile conditions after opening at -20℃. Avoid freeze-thaw cycles. |
| Shipping Condition | Shipped on ice packs. |
| Product Declaration | 本产品仅用于研究用途(RUO)。不能用于诊断或直接用于人体实验。 |
| Product Full Name | Rabbit Anti-Human AHSA1 Polyclonal Antibody |
FAQ
-
Q1-AHSA1的分子功能是什么？
AHSA1（Hsp90辅助ATP酶激活蛋白）调控Hsp90的ATP酶活性，参与应激反应和癌症耐药性。
-
Q2-是否适用于研究Hsp90抑制剂（如17-AAG）的作用机制？
可以，通过检测Hsp90抑制剂处理后的AHSA1表达变化，结合Co-IP验证复合体稳定性。
-
Q3-Western Blot中如何区分AHSA1与其他Hsp辅助因子？
预期分子量约38 kDa，需通过siRNA敲低或KO细胞样本验证条带特异性。
-
Q4-抗体是否与Hsp70或Hsp40交叉反应？
经测试无交叉反应，特异性针对AHSA1。
-
Q5-免疫荧光中如何增强应激颗粒信号？
使用热休克（42℃，1小时）诱导应激颗粒形成，并用抗TIA-1抗体共定位验证。
- Protein Platform
- Protein Expression Services
- Protein Modification & Detection Services
- Protein Interaction Services
- Protein Purification Service
- Antibody Discovery Platform
- VHH Antibody Platform
- Phage Display Platform
- Antibody Humanization Platform
- Single B Cell Screening Platform
- Antibody Expression & Validation Platform
- Peptide Library Platform
- Custom Antibody Platform
- Innovative Drug Discovery Platform
- Product Center
- Proteins
- Antibodies
- Raw Materials Reagents
- Small Molecule Reagents
- Peptide Products
- Nanoparticle Products
- Contact Us
- Phone：400-621-6806
- Mobile：13110936064（WeC
- E-mail：[email protected]
- Address：Room 108, Building 10, No. 6 Hechang Road, Wuqing Development Zone, Tianjin City
-
WeChat
-
Service Account
-
400-621-6806 -
3599163699 -
Monday to Friday 9:00-18:00 -
-
0
-
